Brainsway Deep TMS Therapy - for Brain Disorder Treatment

Evaluation of the H1-Coil Transcranial Magnetic Stimulation (TMS) Device – Safety and Feasibility study for Treatment of Major Depressive Episode in the elderly

Shalvata Mental Health Center, Israel

11 March 2012

The purpose of this study is to evaluate the safety and anti-depressive response of the H1 Coil TMS Device in elderly patients suffering from major depressive episode.

A randomized, sham-controlled trial is now conducted at Shalvata Mental-Health Center. Its aim is to evaluate the efficacy and safety of H1-coil Deep TMS in subjects with Major Depression, currently treated by mood stabilizers. 

Contact: 

Yaara Krueger
yaarakr@post.tau.ac.il
 
Daphna Fenchel
fenchel@post.tau.ac.il
 
Noah Aaron
noahaa@post.tau.ac.il
 
Tel: 972-9-7478644

Principal Investigator: Prof. Hilik Levkovitz


© Brainsway Ltd.® 2014 | All rights reserved. Patients Portal · Brainsway Deep TMS · FDA Clearance · Disclaimer · Privacy Policy · Terms of Use